Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma
Clinical trial NCT03669445 · UNKNOWN
Trial details
- NCT number
- NCT03669445
- Sponsor
- University Hospital, Toulouse
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2024-03-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.